Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence Study.
Elisavet ChorafaElias IosifidisAndrea OlettoAdilia WarrisElio CastagnolaRoger BruggemannAndreas H GrollThomas LehrnbecherLaura Ferreras AntolinAlessio MesiniEleni AgakidouTiziana ControzziMaia De LucaGabriel DimitriouMarieke EmontsSusanna EspositoAurora Fernàndez-PoloElisabetta Ghimenton-WaltersDespoina GkentziCarlos GrasaEleftheria HatzidakiPiia JõgiKornelija KildonaviciuteAngeliki KontouAlessa Leibold-AguinarteAngela ManzanaresNatalia Mendoza-PalomarTuuli MetsvahtMaria NoniStéphane PaulusSerafina PerroneElena Rincón-LópezLorenza RomaniLaura SánchezBenhur Sirvan CetinVana SpoulouVolker StrengerEleni VergadiSerena VillaverdeMarco VuerichElena Zamora-FloresEmmanuel RoilidesPublished in: The Pediatric infectious disease journal (2024)
Antifungal usage in European NUs is driven by prophylaxis and empirical treatment with fluconazole being the most prescribed agent for both indications.